Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 7

Sistemik sklerozlu hastalarda kardiyovasküler tutulum: Kalbin elektromekanik özelliklerinden çıkarsamalar

Cardiovascular involvement in patients with systemic sclerosis: Insights from electromechanical characteristics of the heart

Pages
643–647
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we intend to present cardiac involvement of systemic sclerosis and clinical diagnostic modalities, including electromechanical properties of the atrium and ventricles, for assessment this involvement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic sclerosis is a severe, life threatening autoimmune disease involving the skin and visceral organs, including the lungs, gastrointestinal tract, kidneys and heart.
📊
Key Findings & Data:Cardiac involvement in systemic sclerosis, which is an important mortality predictor may involve myocardium, conduction system, vascular wall, pericardium, pulmonary vessels causing pulmonary hypertension.
💡
Conclusion & Impact:In this review, we intend to present cardiac involvement of systemic sclerosis and clinical diagnostic modalities, including electromechanical properties of the atrium and ventricles, for assessment this involvement.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Systemic sclerosis is a severe, life threatening autoimmune disease involving the skin and visceral organs, including the lungs, gastrointestinal tract, kidneys and heart. Cardiac involvement in systemic sclerosis, which is an important mortality predictor may involve myocardium, conduction system, vascular wall, pericardium, pulmonary vessels causing pulmonary hypertension. Thus, the detection of cardiac involvement is necessary in systemic sclerosis. With the more widespread use of novel non-invasive imaging techniques, the cardiac involvement is more frequently encountered in daily practice. Noninvasive evaluation can offer an advantage in early prediction of poor prognosis and give a chance to apply new therapeutic approaches for cardiac involvement. In this review, we intend to present cardiac involvement of systemic sclerosis and clinical diagnostic modalities, including electromechanical properties of the atrium and ventricles, for assessment this involvement.

Özet

Sistemik skleroz; kalp, böbrek, mide-bağırsak sistemi, akciğer gibi iç organları ve deriyi tutan önemli ve hayatı tehdit edici otoimmün bir hastalıktır. Pulmoner hipertansiyona yol açan pulmoner damar tutulumu, perikart, damar duvarı, ileti sistemi ve miyokart tutulumu şeklinde olan kalp tutulumunun varlığı önemli bir ölüm belirtecidir. Bu nedenle, sistemik sklerozlu hastalarda kalp tutulumunu tespit etmek gerekmektedir. Bu tutulumu, girişimsel yöntemler yerine girişimsel olmayan yöntemlerle saptayabilmek amacıyla yapılan çalışmalar yeni görüntüleme yöntemleri ışığında gün geçtikçe artmaktadır. Girişimsel olmayan değerlendirmeler; olası kötü sonlanım noktalarının erken öngörülmesinde avantajlı olabilir ve sistemik sklerozlu hastalardaki kardiyak tutulumu hedef alan yeni tedavi yaklaşımlardan yararlanma fırsatı yaratabilir. Bu derlemede, sistemik sklerozun kalp tutulumunu ve bu tutulumu göstermek amacıyla kullanılan atriyum ve ventrikül elektromekanik özellikler de dahil olmak üzere, tanısal yöntemleri sunmak istedik.

🔖

Cite This Article

KARABAY, C. Y., KARAAHMET, T., TİGEN, K. (2022). Sistemik sklerozlu hastalarda kardiyovasküler tutulum: Kalbin elektromekanik özelliklerinden çıkarsamalar. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 7, 643–647. https://ajindex.com/articles/436677

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Olski TM, Hunzelmann N. Immunosuppressive and antifibrotic therapy of systemic sclerosis. Expert Rev Dermatol 2007
  2. [CrossRef] 2. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005
  3. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 2003
  4. [CrossRef] 4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980
  5. Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 2005
  6. [CrossRef] 6. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999
  7. [CrossRef] 7. Roman MJ, Salmon JE. Cardiovascular manifestations of rheumatologic diseases. Circulation 2007
  8. [CrossRef] 8. Karaahmet T, Tigen K, Gürel E, Takır M, Avcı A, Çevik C, et al. Impact of systemic sclerosis on electromechanical characteristics of the heart. Heart Vessels 2010
  9. [CrossRef] 9. Follansbee WP, Miller TR, Curtiss EI, Orie JE, Bernstein RL, Kiernan JM, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990
  10. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976
  11. [CrossRef] 11. Follansbee WP, Curtiss EI, Medsger TA, Steen VD, Uretsky BF, Owens GR, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984
  12. [CrossRef] 12. Kahan A, Devaux JY, Amor B, Menkès CJ, Weber S, Nitenberg A, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986
  13. [CrossRef] 13. Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology 2006
  14. [CrossRef] 14. Vignaux O, Allanore Y, Meune C, Pascal O, Duboc D, Weber S, et al. Evaluation of the effect of nifedipine upon myocardial perfusion